The lawyer spoke about measures to accelerate the inclusion of drugs in the list of state guarantees.

The improvement of the regulatory framework and the expansion of Decree No. 403 will provide patients with rare diseases with wider access to innovative medicines. Natalia Smirnova, a first-class lawyer and member of the expert council of the State Duma Committee on Health Protection for Rare Diseases, told about this on October 13 at the Izvestia press center at a press conference on: "Lists of state guarantees for orphan patients. For the state or for patients? How to negotiate."

"We can expand Resolution No. 403 both on the full list of 22 diseases, and start with those that are most widespread when leaving the care of the Circle of Goodness Foundation. This is a logical direction that will have a quick effect," the expert explained.

Answering a question about the problems in the regions where patients face refusal to prescribe innovative drugs that are not included in the list of vital and essential medicines, Smirnova noted that the legislation does not prohibit such prescriptions.

"The question here is not the list of VED, but whether the drug is prescribed to the patient. By decision of the medical commission, medicines that are not included in the list may be used. There are no legal restrictions on this," the lawyer stressed.

Smirnova also suggested adjusting the timing of the formation of VED lists in order to speed up the inclusion of new drugs in the system.

"If we postpone the formation of the list and the program of state guarantees to an earlier period, the Ministry of Health and the government will be able to take into account new drugs in advance. This will avoid delays in their inclusion in the CSG [clinical and statistical groups]," the lawyer noted.

Stop the blood: patients with hemophilia risk their lives due to non-administration of drugs

Suppliers did not go to auctions due to the low stated price, the Ministry of Health explained.

State Duma Deputy, President of the Dmitry Rogachev National Research Medical Center for Pediatric Hematology, Oncology and Immunology, Academician of the Russian Academy of Sciences Alexander Rumyantsev told the Izvestia News Center on March 25 that technologies for the treatment and diagnosis of orphan (rare) diseases are rapidly developing in Russia.

The news is being updated

All important news is on the Izvestia channel in the MAX messenger.